iFAST Diagnostics

📍 Southampton, United Kingdom🗓 Founded 2022👥 31 employees💰 Last funded Feb 2025
Medical and Diagnostic Laboratories🌐 ifastdiagnostics.com
Website LinkedIn
iFAST is developing a game-changing, rapid antimicrobial susceptibility test, that will enable every patient with bacterial infections to receive the right antibiotic, on time, every time. Currently, these tests take 48-72 hours, but iFASTs tests are 10x faster - giving full quantitative and qualitative results in under 3 hours from a positive blood culture or bacterial isolate. The technology is cheaper and involve less tedious manual labour than current standard of care, which is based on technology from the mid-1900s! We also offer high throughout (most labs only need one system to accommodate all their requirements). This is a $4bn market and we will be launching on the UK market at the start of 2026, and in the US and EU the following year.
2
Total investors
1
Early stage
1
Mid stage
0
Late stage
2022
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United Kingdom
2
Frequently asked questions
Who invested in iFAST Diagnostics?
iFAST Diagnostics has 2 investors on record on gritt.io, including 1 early-stage backers, 1 mid-stage.
When did iFAST Diagnostics last raise funding?
The most recent investment in iFAST Diagnostics recorded on gritt.io was in February 2025.
When was iFAST Diagnostics founded?
iFAST Diagnostics was founded in 2022.
What industry is iFAST Diagnostics in?
iFAST Diagnostics operates in Medical and Diagnostic Laboratories. Find similar Medical and Diagnostic Laboratories investors on gritt.io.
Where is iFAST Diagnostics based?
iFAST Diagnostics is headquartered in Southampton, United Kingdom.